Frankfurt
15.05.25 | 09:15
0,000 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.04. | Summary from Annual General Meeting of Episurf Medical AB (publ) | 2 | Cision News | ||
| 10.04. | Episurf Medical AB: Interim Report 1 January - 31 March 2025 | 74 | GlobeNewswire (Europe) | • Continued increases in sales and gross order intake combined with lower expense level
• Significant increase in European sales organisation through co-operation with Joint Operations
• First surgeries... ► Artikel lesen | |
| 31.03. | Change in number of shares and votes in Episurf Medical | 1 | Cision News | ||
| 19.03. | Episurf Medical to present at Redeye Theme Event: Commercialization in Life Science | 2 | Cision News | ||
| 18.03. | Episurf Medical AB: CFO Veronica Wallin leaves Episurf Medical for a new position | 136 | GlobeNewswire (Europe) | Veronica Wallin, Episurf Medical's CFO since June 2017 and previously Head of Finance since August 2016, has today announced her resignation from Episurf for a new opportunity.
"It's almost 9 years... ► Artikel lesen | |
| EPISURF MEDICAL Aktie jetzt für 0€ handeln | |||||
| 11.03. | Notice of Annual General Meeting of Episurf Medical AB (publ) | 3 | Cision News | ||
| 06.03. | Episurf Medical AB's 2024 annual report is now available | 1 | Cision News | ||
| 25.02. | Episurf Medical AB announces outcome of exercise of warrants of series TO13 B | 1 | Cision News | ||
| 05.02. | Episurf Medical AB: Year-End Report 1 January - 31 December 2024 | 90 | GlobeNewswire (Europe) | Significant result and cash flow improvements
Distribution agreement with Joint Operations for several European markets
First sales through the Johnson & Johnson distributor network
"We hereby... ► Artikel lesen | |
| 05.02. | Episurf Medical enters into distribution agreement for several European countries with Joint Operations Ltd | 1 | Cision News | ||
| 29.01. | Update on the Episurf MTP implant - response to FDA submitted | 2 | Cision News | ||
| 30.12.24 | New patent approvals for Episurf Medical | 3 | Cision News | ||
| 27.12.24 | US VAC permissions granted for Episurf Medical | 1 | Cision News | ||
| 03.12.24 | Episurf Medical to present at Redeye Technology & Life Science Day on December 3rd, 2024 | 1 | Cision News | ||
| 25.10.24 | Episurf Medical AB: Interim Report 1 January - 30 September 2024 | 118 | GlobeNewswire (Europe) | Improvement of financial result through lower cost base and increased revenues
Focus towards expansion of US sales force
Continued progress of 510(k)-process for great toe implant
"I am pleased... ► Artikel lesen | |
| 12.07.24 | Episurf Medical AB: Interim Report 1 January - 30 June 2024 | 148 | GlobeNewswire (Europe) | 45% sales growth despite transformation of sales organization
Additional SEK 12m in annual cost savings identified
Pause of EPIC-Knee trial to the advantage of other initiatives
"We have started... ► Artikel lesen | |
| 27.06.24 | Nasdaq Stockholm AB: New equity right for trading, Episurf Medical AB TO 13 | 322 | GlobeNewswire | At the request of Episurf Medical AB , Episurf Medical AB equity rights will be
traded on First North Growth Market as from June 28, 2024.
Security name: Episurf Medical AB TO 13
----------------------------------------
Short... ► Artikel lesen | |
| 27.05.24 | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Episurf Medical AB | 460 | GlobeNewswire | With effect from May 28, 2024, the unit rights in Nasdaq will be traded on the
list for Equity rights. Trading will continue up until and including June 07,
2024.
Instrument: Unit rights ... ► Artikel lesen | |
| 24.05.24 | Episurf Medical AB: Episurf Medical publishes prospectus in connection with the company's partially guaranteed rights issue of up to approximately SEK 120 million | 411 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA... ► Artikel lesen | |
| 22.05.24 | Episurf Medical AB: Summary From The Extraordinary General Meeting Of Episurf Medical AB (publ) | 173 | GlobeNewswire (Europe) | Episurf Medical AB (publ) held an Extraordinary General Meeting in Stockholm today 22 May 2024 at which it was resolved, among other things, to approve the Board of Directors' resolution on a rights... ► Artikel lesen |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IMUNON | 0,540 | -1,82 % | Imunon, Inc.: IMUNON Announces Six-Month Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Trial in COVID-19 | Company's PlaCCine® technology platform demonstrates better durability and other advantages compared to mRNA vaccines Results further validate PlaCCine as a novel vaccine platform with potential applications... ► Artikel lesen | |
| ELECTROCORE | 4,360 | 0,00 % | ElectroCore anticipates $30M 2025 revenue amid product line expansion | ||
| FRESENIUS | 42,520 | +1,80 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
| UNITEDHEALTH | 245,05 | -11,15 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,850 | +1,45 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 50,84 | +1,68 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
| CARL ZEISS MEDITEC | 61,20 | -1,13 % | Ihre wichtigsten Termine: Alle Blicke auf: Boeing, Bayer, Carl Zeiss Meditec, Rheinmetall, Sixt & Jenoptik | © Foto: Bayer AGGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:00 Uhr, Deutschland:... ► Artikel lesen | |
| KINDLY MD | 13,830 | +81,50 % | David Bailey and Bitcoin-Native Holding Company Nakamoto Announce Merger with KindlyMD to Establish Bitcoin Treasury | Raises $510 Million PIPE and $200 Million in Convertible Notes Marking Largest Capital Raise to Launch a Bitcoin Treasury and the Largest PIPE for Any Public Crypto-Related Transaction
David Bailey... ► Artikel lesen | |
| GERRESHEIMER | 62,20 | +0,48 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Nachhaltigkeit
Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab
12.05.2025... ► Artikel lesen | |
| HIMS & HERS HEALTH | 52,24 | -4,60 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
| GENEDX | 63,73 | +7,09 % | GeneDx Holdings stock trades higher as upgraded at Jefferies | ||
| ECKERT & ZIEGLER | 63,25 | +1,28 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Quartalsergebnis
Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose
13.05.2025 / 07:45... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 58,15 | +6,21 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| NUTEX HEALTH | 174,34 | +9,92 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| THERMO FISHER | 361,85 | -0,44 % | Cybin taps Thermo Fisher for potential commercial manufacturing of CYB003 |
EPISURF MEDICAL AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EPISURF MEDICAL AB finden Sie auf Wallstreet Online.